Quantong Wu

Mr. Quantong Wu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
QWQuantong Wu
Quantong Wu
FXFuchao Xu
Fuchao Xu
JWJie Wang
Jie Wang
MJMing Jiang
Ming Jiang
(1) Purpose: to systematically evaluate the recovery following sedation and anesthesia with remimazolam combined with flumazenil in comparison to propofol. (2) Methods: Electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, were systematically searched from their inception up to 22 October 2023. Included in this analysis were randomized controlled trials (RCT) that compared remimazolam–flumazenil with propofol for the recovery from sedation and anesthesia in adults. The risk of bias was assessed using the Cochrane risk of bias tool. Pooled risk ratios (RR) or mean differences (MD) along with their corresponding 95% confidence intervals (CI) were calculated using either fixed-effects or random-effects models, and the results were visualized in forest plots. (3) Results: Nine RCTs involving 745 patients who underwent general anesthesia in three different countries were included. Compared to propofol, the remimazolam–flumazenil combination shortened the emergence time (MD = −4.34 min, 95% CI = [−6.88, −1.81], p = 0.0008, low certainty), extubation time (MD = −4.26 min, 95% CI = [−6.81, −1.7], p = 0.0011, low certainty), and the post-anesthesia care unit (PACU) stay (MD = −4.42 min, 95% CI = [−7.45, −1.38], p = 0.0044, low certainty), while reducing the incidence of respiratory depression (RR = 0.2, 95% CI = [0.04, 0.89], p = 0.03, high certainty) after general anesthesia. However, this combination was associated with a higher incidence of re-sedation (RR = 4.15, 95% CI = [1.31, 13.13], p = 0.01, moderate certainty). (4) Conclusions: Based on the existing evidence, the combination of remimazolam and flumazenil accelerates recovery from general anesthesia and lowers the risk of respiratory depression compared to propofol. However, it is important to consider the higher risk of re-sedation when using this combination in clinical practice. Due to limitations in the quality of the evidence, it is advisable to interpret the results of meta-analyses with caution.

1 February 2024 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
QWQuantong Wu
Quantong Wu
FXFuchao Xu
Fuchao Xu
JWJie Wang
Jie Wang
MJMing Jiang
Ming Jiang
Purpose: To systematically evaluate the effectiveness and safety of ketamine in preventing propofol injection pain (PIP). Patients and Methods: The electronic databases including PubMed, Embase, Web of Science, and Cochrane Library were searched from their inception until 2 August 2023. Randomized controlled trials (RCT) comparing ketamine with placebo or other interventions to alleviate PIP in adults were included. Fixed-effects or random-effects models were used to calculate pooled risk ratios (RR) and corresponding 95% confidence intervals (CI) based on the heterogeneity of the studies included. Results: Thirteen RCTs involving 2105 patients were included. In terms of reducing the incidence of PIP, ketamine is more effective than placebo (RR = 0.43, 95% CI = [0.34, 0.55], P < 0.00001), lidocaine (RR = 0.70, 95% CI = [0.55, 0.90], P = 0.005), dexmedetomidine (RR = 0.52, 95% CI = [0.40, 0.66], P < 0.00001), and thiopental (RR = 0.25, 95% CI = [0.08, 0.83], P = 0.02). In reducing the incidence of severe PIP, ketamine is superior to placebo (RR = 0.12, 95% CI = [0.08, 0.19], P < 0.00001), and lidocaine (RR = 0.34, 95% CI = [0.21, 0.56], P < 0.0001), except dexmedetomidine (RR = 0.20, 95% CI = [0.04, 1.13], P = 0.07), and thiopental (RR = 0.33, 95% CI = [0.04, 3.10], P = 0.33). Compared with mixed injection, separate injection of ketamine and propofol showed no significant difference in the incidence of PIP (RR = 0.96, 95% CI = [0.31, 3.00], P = 0.95) and severe PIP (RR = 1.19, 95% CI = [0.07, 21.29], P = 0.90). Based solely on the reports from the studies included, subanesthetic doses of ketamine are generally safe in preventing PIP. Conclusion: A subanesthetic dose of ketamine can effectively and safely reduce the incidence of PIP and severe PIP in adults, and is more effective than lidocaine, dexmedetomidine, and thiopental. Registration: PROSPERO CRD42023455093.

22 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
FXFuchao Xu
Fuchao Xu
QWQuantong Wu
Quantong Wu
SGShuangshuang Gu
Shuangshuang Gu
GLGeng Lu
Geng Lu
JWJun Wang
Jun Wang
Background: The optimal timing of enteral nutrition for critically ill septic patients in the intensive care unit (ICU) who require invasive mechanical ventilation has not been determined, and the influence of early enteral nutrition on clinical outcomes is unclear. Methods: This retrospective observational study utilized data from the Medical Information Mart for Intensive Care IV 2.2 (MIMIC-IV 2.2) database to investigate patients with sepsis who needed invasive mechanical ventilation post-ICU admission. Patients who had enteral nutrition (EN) initiated within 72 hours of ICU were categorized into the early enteral nutrition (EEN) group, while those who began enteral nutrition after 72 hours were placed in the delayed enteral nutrition (DEN) group. Propensity score matching analysis was performed to compare outcomes between these two groups, with the primary outcome being 28-day mortality. Results:The final analysis included 2293 patients, 1546 (67.4%) of whom received enteral nutrition within 72 hours of invasive mechanical ventilation. The overall 28-day mortality rate was 31.0%. After propensity score matching employing the proximity matching method, Cox survival analysis revealed that early enteral nutrition was associated with increased 28-day mortality in septic patients on invasive mechanical ventilation (hazard ratio(HR) 1.440 , 95% CI 1.179–1.760; p <0.001). The sensitivity and robustness of the evaluation results under different models, including optimal matching (adjusted odds ratio(aOR) 1.54, 95% CI 1.22–1.93, p < 0.001), inverse probability of treatment weighting (aOR 1.27, 95% CI 1.02–1.58, p = 0.035), and logistic regression analysis (aOR 1.48, 95% CI 1.18–1.84, p = 0.001), confirmed the detrimental effects of early enteral nutrition on invasive mechanical ventilation in septic patients. Subgroup analyses of the original data indicated that early enteral nutrition may be particularly harmful in mechanically ventilated septic shock patients and severely ill young female patients. Conclusions: Compared to delayed enteral nutrition, early enteral nutrition increases 28-day mortality in septic patients on invasive mechanical ventilation, especially in septic shock patients and severely ill young female patients on invasive mechanical ventilation. Randomized controlled trials are warranted to compare the efficacy of early and delayed enteral nutrition in septic patients requiring invasive mechanical ventilation.